Chemed Corp (CHE) Earnings Call Analysis

NYSE · Healthcare · Medical Care Facilities

21/25

Growth 5 Margin 5 Expansion 4 Platform 2 Financial 5

latest quarter score

Earnings Reports

21
ChemEd (CHE) Q2 2026: VITAS Admissions Jump 9% as Margin Guidance Rises
July 29, 2026
13
Chemed (CHE) Q1 2026: VITAS Admissions Up 6.9% as Roto-Rooter Paid Leads Hit 53%
April 24, 2026
7
ChemEd (CHE) Q4 2025: Roto-Rooter Paid Leads Up 9.4% as Digital Mix Reshapes Margin Trajectory
February 26, 2026
7
Chemed (CHE) Q3 2025: Paid Leads Jump 8.6%, Margin Recovery Hinges on Discipline
October 29, 2025
8
ChemEd (CHE) Q2 2025: Roto-Rooter Margin Drops 517bps as Digital Lead Shift Squeezes Profitability
July 30, 2025
13
ChemEd (CHE) Q1 2025: VITAS Admissions Jump 7.3% as Medicare Cap Strategy Reshapes Growth Profile
July 06, 2025

Browse all companies